Skip to content
Recombinetics Logo Recombinetics Logo Recombinetics Logo
  • About
    • Our Company
    • Our Team
    • Our Technology
  • Solutions
    • for Transplantable Cells, Tissues & Organs for Patients
    • for Accelerating Drug, Device & Gene Therapy Development
    • for Food Animal Health, Welfare & Sustainability
  • Newsroom
    • News
    • Publications
  • Contact
  • About
    • Our Company
    • Our Team
    • Our Technology
  • Solutions
    • for Transplantable Cells, Tissues & Organs for Patients
    • for Accelerating Drug, Device & Gene Therapy Development
    • for Food Animal Health, Welfare & Sustainability
  • Newsroom
    • News
    • Publications
  • Contact
  • About
    • Our Company
    • Our Team
    • Our Technology
  • Solutions
    • for Transplantable Cells, Tissues & Organs for Patients
    • for Accelerating Drug, Device & Gene Therapy Development
    • for Food Animal Health, Welfare & Sustainability
  • Newsroom
    • News
    • Publications
  • Contact

People On the Move: Mitchell Abrahamsen

IT ADMIN2017-07-11T15:45:42-05:00

Categories

  • Industry News
  • News
  • Press Releases

Recent Posts

  • Rocco Morelli Named Interim Ceo Of Recombinetics™, Global Leader In Genetically Engineered Animals
  • Makana Statement about Transplant of Gal-Knockout Pig Kidney into a Recently Deceased Human with an Intact Circulation
  • Makana Therapeutics – 2021 KidneyX “Artificial Kidney Prize – Phase 1” Winner
  • Makana Therapeutics Awarded KidneyX Artificial Kidney Prize for Innovation in Xenotransplantation
  • First GM pigs for allergies. Could xenotransplants be next?
Recombinetics logomark

3388 Mike Collins Drive, Eagan, MN 55121
612-727-2000
info@recombinetics.com

Makana logoSarxion logotherillume logo Acceligen logo
COPYRIGHT 2020 RECOMBINETICS   |   ALL RIGHTS RESERVED
Page load link
Go to Top